GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » EBIT

Dolby Laboratories (Dolby Laboratories) EBIT

: $227 Mil (TTM As of Dec. 2023)
View and export this data going back to 2005. Start your Free Trial

Dolby Laboratories's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $72 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $227 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dolby Laboratories's annualized ROC % for the quarter that ended in Dec. 2023 was 13.05%. Dolby Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 52.27%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Dolby Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.39%.


Dolby Laboratories EBIT Historical Data

The historical data trend for Dolby Laboratories's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 282.48 239.90 340.76 217.23 262.81

Dolby Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.84 109.26 23.87 21.63 72.31

Competitive Comparison

For the Specialty Business Services subindustry, Dolby Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolby Laboratories EV-to-EBIT Distribution

For the Business Services industry and Industrials sector, Dolby Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dolby Laboratories's EV-to-EBIT falls into.



Dolby Laboratories EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $227 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dolby Laboratories  (NYSE:DLB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dolby Laboratories's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=289.248 * ( 1 - 16.39% )/( (1836.889 + 1869.504)/ 2 )
=241.8402528/1853.1965
=13.05 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2979.766 - 258.365 - ( 884.512 - max(0, 422.226 - 1487.804+884.512))
=1836.889

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2935.529 - 268.386 - ( 797.639 - max(0, 394.096 - 1451.355+797.639))
=1869.504

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Dolby Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=289.248/( ( (521.78 + max(12.564, 0)) + (517.322 + max(54.983, 0)) )/ 2 )
=289.248/( ( 534.344 + 572.305 )/ 2 )
=289.248/553.3245
=52.27 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(262.245 + 35.623 + 123.294) - (258.365 + 31.505 + 118.728)
=12.564

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(293.228 + 37.568 + 105.361) - (268.386 + 33.404 + 79.384)
=54.983

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Dolby Laboratories's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=227.073/6702.839
=3.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dolby Laboratories EBIT Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Dolby Laboratories (Dolby Laboratories) Business Description

Traded in Other Exchanges
Address
1275 Market Street, San Francisco, CA, USA, 94103-1410
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Executives
Kevin J Yeaman officer: VP, Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman officer: EVP, GEN. COUN. & SECRTY DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling officer: SVP, Entertainment C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton officer: SVP, Chief Marketing Officer 1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud director C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian director DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher director
Ryan Nicholson officer: VP, Corporate Controller C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar officer: SVP, Advanced Technology Group C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet director 9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park officer: SVP & Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay officer: Sr. Vice President, Research 1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew officer: EVP, Chief Financial Officer DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103